Journal article
Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis
Abstract
In this 2-week, randomized, crossover study, ophthalmic solutions of nedocromil sodium 2% and olopatadine hydrochloride 0.1% were compared for effectiveness and acceptability in 28 patients with perennial allergic conjunctivitis and previous olopatadine experience. Patients received nedocromil twice daily or olopatadine twice daily for 1 week, then were crossed over to the alternate medication for 1 week. Outcome measures were patient …
Authors
Alexander M; Allegro S; Hicks A
Journal
Advances in Therapy, Vol. 17, No. 3, pp. 140–147
Publisher
Springer Nature
Publication Date
May 2000
DOI
10.1007/bf02853155
ISSN
0741-238X